Aurinia Pharmaceuticals Inc. SC 13D and SC 13D/A reports

Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada
Fiscal year end
December 31
Data updated at
9/14/2024, 04:05 AM
Form type Sec Links Description Filing date Reporting date
SC 13D Report Sep 12, 2024
SC 13D/A Report SC 13D/A Mar 20, 2024
SC 13D/A Report SC 13D/A May 10, 2023
SC 13D/A Report SC 13D/A Jan 20, 2023
SC 13D/A Report SC 13D/A Jan 6, 2023
SC 13D/A Report SC 13D/A Mar 3, 2022
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND III, LLC (AURINIA) - SCHEDULE 13DA1E Mar 11, 2021
SC 13D/A Report SC 13D/A Jan 27, 2021
SC 13D/A Report SC 13D/A Jan 26, 2021
SC 13D/A Report SC 13D/A Oct 9, 2020
SC 13D/A Report AMENDMENT Jul 23, 2020
SC 13D/A Report SC 13D/A Dec 18, 2019
SC 13D/A Report SC 13D/A Dec 10, 2019
SC 13D/A Report SC 13D/A Dec 9, 2019
SC 13D/A Report SC 13D/A Dec 6, 2019
SC 13D/A Report SC 13D/A Nov 13, 2019
SC 13D/A Report SC 13D/A Jun 4, 2019
SC 13D Report SC 13D Apr 8, 2019
SC 13D/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13D Jan 18, 2019
SC 13D/A Report Oct 23, 2017
SC 13D Report THE SCHEDULE 13D May 1, 2017
SC 13D/A Report SC 13D/A Mar 27, 2017
SC 13D Report GROWTH EQUITY OPPORTUNITIES FUND III, LLC / AURINIA PHARMACEUTICALS INC. Jan 9, 2017
SC 13D/A Report FORM SC 13D/A Jan 5, 2017
SC 13D Report SCHEDULE 13D Jul 5, 2016